Merlin neutralizes the inhibitory effect of Mdm2 on p53

被引:54
作者
Kim, H
Kwak, NJ
Lee, JY
Choi, BH
Lim, Y
Ko, YJ
Kim, YH
Huh, PW
Lee, KH
Rha, HK
Wang, YP
机构
[1] Catholic Univ Korea, Neurosci Genome Res Ctr, Seoul 137701, South Korea
[2] Catholic Univ Korea, Dept Occupat & Environm Med, Seoul 137701, South Korea
[3] Catholic Univ Korea, Dept Pharmacol, Seoul 137701, South Korea
[4] Catholic Univ Korea, Dept Thorac & Cardiovasc Surg, Seoul 137701, South Korea
关键词
D O I
10.1074/jbc.M305526200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The stability of p53 tumor suppressor is regulated by Mdm2 via the ubiquitination and proteasome-mediated proteolysis pathway. The c-Abl and PTEN tumor suppressors are known to stabilize p53 by blocking the Mdm2-mediated p53 degradation. This study investigated the correlation between p53 and merlin, a neurofibromatosis 2 ( NF2)-related tumor suppressor, in association with the Mdm2 function. The results showed that merlin increased the p53 stability by inhibiting the Mdm2-mediated degradation of p53, which accompanied the increase in the p53-dependent transcriptional activity. The stabilization of p53 by merlin appeared to be accomplished through Mdm2 degradation, and the N-terminal region of merlin was responsible for this novel activity. This study also showed that overexpression of merlin-induced apoptosis of cells depending preferentially on p53 in response to the serum starvation or a chemotherapeutic agent. These results suggest that merlin could be a positive regulator of p53 in terms of tumor suppressor activity, and provide the promising therapeutic means for treating tumors with non-functional merlin or Mdm2 overexpression.
引用
收藏
页码:7812 / 7818
页数:7
相关论文
共 39 条
[21]   A phosphatidylinositol 3-kinase/Akt pathway promotes translocation of Mdm2 from the cytoplasm to the nucleus [J].
Mayo, LD ;
Donner, DB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (20) :11598-11603
[22]   Mice heterozygous for a mutation at the Nf2 tumor suppressor locus develop a range of highly metastatic tumors [J].
McClatchey, AI ;
Saotome, I ;
Mercer, K ;
Crowley, D ;
Gusella, JF ;
Bronson, RT ;
Jacks, T .
GENES & DEVELOPMENT, 1998, 12 (08) :1121-1133
[23]   THE MDM-2 ONCOGENE PRODUCT FORMS A COMPLEX WITH THE P53 PROTEIN AND INHIBITS P53-MEDIATED TRANSACTIVATION [J].
MOMAND, J ;
ZAMBETTI, GP ;
OLSON, DC ;
GEORGE, D ;
LEVINE, AJ .
CELL, 1992, 69 (07) :1237-1245
[24]   The NF2 tumor suppressor gene product, merlin, mediates contact inhibition of growth through interactions with CD44 [J].
Morrison, H ;
Sherman, LS ;
Legg, J ;
Banine, F ;
Isacke, G ;
Haipek, CA ;
Gutmann, DH ;
Ponta, H ;
Herrlich, P .
GENES & DEVELOPMENT, 2001, 15 (08) :968-980
[25]   ONCOPROTEIN MDM2 CONCEALS THE ACTIVATION DOMAIN OF TUMOR SUPPRESSOR-P53 [J].
OLINER, JD ;
PIETENPOL, JA ;
THIAGALINGAM, S ;
GVURIS, J ;
KINZLER, KW ;
VOGELSTEIN, B .
NATURE, 1993, 362 (6423) :857-860
[26]   ALTERATION IN A NEW GENE ENCODING A PUTATIVE MEMBRANE-ORGANIZING PROTEIN CAUSES NEUROFIBROMATOSIS TYPE-2 [J].
ROULEAU, GA ;
MEREL, P ;
LUTCHMAN, M ;
SANSON, M ;
ZUCMAN, J ;
MARINEAU, C ;
HOANGXUAN, K ;
DEMCZUK, S ;
DESMAZE, C ;
PLOUGASTEL, B ;
PULST, SM ;
LENOIR, G ;
BIJLSMA, E ;
FASHOLD, R ;
DUMANSKI, J ;
DEJONG, P ;
PARRY, D ;
ELDRIGE, R ;
AURIAS, A ;
DELATTRE, O ;
THOMAS, G .
NATURE, 1993, 363 (6429) :515-521
[27]   Transduction of wild-type merlin into human schwannoma cells decreases schwannoma cell growth and induces apoptosis [J].
Schulze, KMM ;
Hanemann, CO ;
Müller, HW ;
Hanenberg, H .
HUMAN MOLECULAR GENETICS, 2002, 11 (01) :69-76
[28]   Interdomain binding mediates tumor growth suppression by the NF2 gene product [J].
Sherman, L ;
Xu, HM ;
Geist, RT ;
SaporitoIrwin, S ;
Howells, N ;
Ponta, H ;
Herrlich, P ;
Gutmann, DH .
ONCOGENE, 1997, 15 (20) :2505-2509
[29]   Tumor surveillance via the ARF-p53 pathway [J].
Sherr, CJ .
GENES & DEVELOPMENT, 1998, 12 (19) :2984-2991
[30]  
SHORT MP, 1994, NEUROFIBROMATOSES PA, P414